We have recently shown that ex vivo high-salt treatment of tumor-primed CD4 + T cells resulted in effector (Th1 and Th17) phenotype activation, and also exerted a strong anti-tumor effect (Figure 2). This evidence concerns the gene CD4 and neoplasm.